NCT06444763

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population

Effect of Maolactin™ FMR Supplementation on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population: A Double-blind Randomized Placebo-controlled Study

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 97 (actual)
• Sponsor: RDC Clinical Pty Ltd · Industry
• Sex: All
• Age: 45 Years
• Healthy volunteers: Accepted

Summary

This is a double blind, randomised, placebo-controlled, parallel-group trial to evaluate the effect of Maolactin FMR supplementation on chronic inflammation, mobility and muscle and joint pain in an otherwise healthy population of adults over 45 years old over 10 weeks with 8 weeks supplementation. This is PART B of the study.

Conditions

• Chronic Inflammation
• Mobility
• Muscle Pain
• Joint Pain

Interventions

Type	Name	Description
DRUG	Maolactin	Once daily dose of 2 capsules containing a total of 500mg/day Maolactin
DRUG	Maltodextrin	Once daily dose of 2 capsules of Maltodextrin containing a total of 0mg/day Maolactin

Timeline

• Start date: 2025-02-27
• Primary completion: 2026-02-16
• Completion: 2026-02-16
• First posted: 2024-06-06
• Last updated: 2026-03-06

Locations

1 site across 1 country: Australia